Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews


Printer Friendly Page Follow BioNews on Twitter BioNews RSS feed

 

Login




News


Personal genomics: just for the rich and famous?

30 May 2007

By Danielle Hamm

Appeared in BioNews 409

There are fears that 'personal genomics' will develop as a tool for the rich and famous, rather than for the benefit of humanity at large, according to a news article in the journal Nature. At a recent scientific meeting, 454 Life Sciences, a US based sequencing technology company, reported that it has sequenced the entire genome of DNA pioneer James Watson. Geneticist Craig Venter is also reported to have sequenced his own genome, and says he has submitted it to the database Genbank prior to publication later this year.

The 'race' to sequence individual human genomes stepped up a gear last year, when the US Archon X Prize Foundation offered a $10m prize for the first company to sequence 100 human genomes in 10 days. It is hoped that the sequencing of individual human genomes will lead to a new age of personalised medicine; where prevention, diagnosis and treatment are tailored to the individual's unique genetic code. Initially, however, people will not learn much from the sequencing of their genome. Scientists are just beginning to interpret genetic information and currently know the genetic signature of very few diseases. The hope is however, that once sequencing the human genome becomes quick and affordable, the analysis of massive amounts of genetic data will facilitate greater understanding of how our genetic makeup influences our health.

Some fear that if the first sequenced genomes are of the rich and famous this will send the wrong message to the wider public - that genomics is for the benefit of the very privileged, rather than the general public. Francis Collins, head of the US National Human Genome Research Institute told Nature: 'If all the sequences obtained over the next year or two are done on scientists with strong financial positions, that will send a message quite contrary to what the genome project aimed to achieve'. Others argue that sequencing scientists' genomes first will defuse public anxiety about the potential misuse of genetic information. The review board that approved another sequencing project, run by George Church of Harvard University, is reported in Nature to have said that 'only people with a masters degree in genetics, or the equivalent, should be allowed to volunteer to ensure that they understand the implications'.

A future world in which everyone has access to their unique genetic code raises potential problems around the ownership of and use of genetic information. For example, knowledge of an individual's genetic make up has implications for that person's blood relatives, because it could reveal certain inherited genetic susceptibilities. The decision to know about one's genetic makeup is a very personal decision and some people may not wish to know, for example, that they have genetic predispositions to life-threatening diseases. There are also fears that genetic information could be misused by employers and insurance companies; or that people will start choosing their reproductive partners partly on the basis of their genetic makeup.

 

SOURCES & REFERENCES
Nature | 24 May 2007
 

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

20 June 2011 - by Ruth Pidsley 
US scientists have reported possibly the first example of using one person's genetic sequence to refine a diagnosis and provide personalised medical treatment. Whole-genome sequencing (WGS) helped pinpoint defects in the DNA of 14-year-old fraternal twins Noah and Alexis Beery causing their rare neurological condition, dopamine-responsive dystonia (DRD)...[Read More]
24 May 2010 - by Naomi Moskovic 
The author of this book was head of the Human Genome Project at the time when the pioneering work to sequence the human genome was carried out. Furthermore, the cover of the paperback carries an endorsement of his work from no less than Barack Obama. So this is an important book...[Read More]
26 August 2008 - by Dr Rachael Panizzo 
As the price of genetic sequencing of an individual's DNA drops, personalized medical genomics will become increasingly integral to prescribing drugs and treating illnesses, leading genome researcher Craig Venter wrote in a commentary for the journal Clinical Pharmacology & Therapeutics. He predicts that genome-based healthcare will help to...[Read More]
21 April 2008 - by Dr Jess Buxton 
James Watson, one of the scientists who reported the double helix structure of DNA in 1953, has now had his own genetic make-up completely decoded. A paper published in the journal Nature last week describes the sequencing of Watson's genome to reveal the precise order of...[Read More]

HAVE YOUR SAY
Be the first to have your say.

You need to Login or Register to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions

 


 

- click here to enquire about using this story.


submit to reddit
Delicious delicious
Facebook

Share on Tumblr


Printer Friendly Page


BioNews Appeal: Please donate HERE to keep BioNews independent and FREE to read


The Progress Educational Trust has been shortlisted for the Charity Times Awards 2011

Good Fundraising Code


Advertise your products and services HERE - click for further details